Rating: Cautiously Bullish | Target Price: RMB 7.7–8.1 (base case, 2026E BPS RMB 12.4 × 0.62–0.65x PB) | Current Price: RMB 7.25 (2026-10-27 close) | Margin of Safety: ~+6% (base fair value floor RMB 7.7 vs. current price) | Time Horizon: 6–12 months | Currency: RMB
Chongqing Rural Commercial Bank (CQRCB) is a regional rural commercial bank dual-listed in A-shares and H-shares (A-share 601077 / H-share 3618.HK) with total assets of RMB 1.79 trillion (2026-06-30), making it the largest listed rural commercial bank in China by assets. All prices and valuations in this report are based on the A-share closing price of RMB 7.25 on 2026-10-27.
CQRCB's 2026 interim report delivered its best revenue performance in five years (+7.81%); net interest margin (NIM) of 1.66% (unverified) widened 6bp year-over-year ahead of the industry at a historic low, and NPL ratio of 1.05% has declined for six consecutive periods. County-level deposit stickiness and a 4.43% dividend yield underpin its core-holding value. At 0.59x PB, the current price trades at an ~11%–12% discount to Shanghai Rural Commercial Bank (0.66x) and Bank of Chongqing (0.67x), whose fundamentals are weaker on multiple dimensions—a horizontal mismatch that offers re-rating room. However, the stock's own valuation percentile is already at an 88% 5-year high, constituting "reasonably cheap" rather than deep undervaluation. Two main constraints: (1) forward-looking retail asset quality indicators have weakened across the board (retail NPL 2.23%, all four migration rates rising, restructured loans +23.8% in half a year); if credit costs merely revert to 1H24 levels, it would erode ~7% of annual profit; (2) on governance, the presidency has been vacant for over three months with no timetable, and the former Chairman was placed under investigation in September 2026 with no conclusion yet. The Q3 results due October 29 will be a triple verification window for NIM, retail NPLs, and governance transmission. Base case fair value: RMB 7.7–8.1 (+6% to +12%); bear case RMB 6.0–6.5 (-17% to -10%); bull case RMB 8.7–8.9 (+20% to +23%). The distribution is right-skewed but modest in magnitude. We are cautiously bullish; investors should build positions gradually, in a dividend core-holding framework, as evidence accrues.
Key evidence:
An objective caveat: the headline growth includes a low-base effect. 1H25 revenue grew only +0.46% YoY with net interest income -5.98%; over two years, net interest income CAGR is ~+10.5% and revenue CAGR ~+4.1%. Moreover, 1H26 other non-interest net income fell -30.43% YoY (the bank proactively trimmed bond gains), so growth was almost entirely driven by net interest income—underpinned by the funding-side dividend of multiple deposit listed-rate cuts since 2025 and repricing of maturing high-rate time deposits. This tailwind will continue to release over the next several quarters (personal deposit cost rate 1.31%, -28bp YoY), but it is temporary rather than a permanent uplift. Quarterly momentum: Q1 +8.39% → Q2 ~+7.24%, decelerating but not stalling. Risks and falsification: if the Q3 report shows 9M26 NIM below 1.64% (the threshold for full-year YoY NIM to stay positive), or management cuts NIM guidance after LPR reductions, this thesis fails.
Key evidence:
The current price requires the market to believe "CQRCB's sustainable ROE is only ~6.8%," whereas reality is FY2025 full-year 9.18% (unverified) and 1H26 annualized 12.0% (unverified) (the bank's profit exhibits marked first-half seasonality—1H25 was 63.5% of full-year net profit—so annualization overstates the full year; we use ~9.2% full-year as the benchmark). The mismatch is real but limited in magnitude. First, the discount embeds structural factors—governance events, higher retail NPLs, and 22% H-share listing—that will not all converge. Second, if the sector's earnings are cut in 2027 on a second NIM trough, the relative discount could also narrow via "peers coming down" rather than "this stock going up." Anchoring basis for the base-case target PB of 0.62–0.65x: the median same-methodology PB of the three comparable peers on 2026-10-27 was 0.67x; we apply a 3%–7% discount given that the retail NPL cycle has not yet been confirmed to have bottomed and governance events have not cleared. We do not use the current 0.59x to self-validate. Risks and falsification: the banking sector pulls back more than 8% from highs and the stock breaks below RMB 6.5; or peers' fundamentals overtake while CQRCB stagnates.
Key evidence:
Dividend certainty is the source of this stock's core-holding value: the 4.43% yield exceeds the average of state-owned large banks, and interim dividends have been institutionalized since 2024. Two constraints must be stated. First, the payout ratio has been "exactly flat" at 30.05% for three years, while the CET1 ratio fell 1.57pct through 2025 to 12.67% and further to 12.33% in 1H26 (both unverified; RWA grew +16.5% in 2025, far above ~6.5% organic capital generation), so room to raise the payout is capital-constrained; the interim dividend amount is subject to the December board announcement (~RMB 0.21–0.22 per share extrapolated from last year's rhythm). Second, in January 2026 six senior executives collectively bought ~192,000 shares for ~RMB 1.23 million (including the former president who had resigned)—less than two hundred-thousandths of market cap, with limited signaling value and not used as a supporting argument. Risks and falsification: the interim dividend plan falls through, or the annual payout ratio drops below 28%.
Key evidence:
This report's adverse-scenario estimate: with retail loans of ~RMB 280.2 billion, if the retail NPL ratio rises to 2.8%–3.0% and consumer loans to 4%+, incremental NPLs would be ~RMB 1.6–2.2 billion; at a 60% net loss rate, the after-tax annual profit impact would be roughly -6% to -8%. Notably, this "stress scenario" merely corresponds to credit costs reverting to 1H24 levels (1H26 credit impairment RMB 1.997 billion vs. RMB 2.457 billion in 1H24)—i.e., it excludes incremental deterioration from rising migration rates. On the cushion side: the 357.47% provision coverage remains thick (among the highest of peers), and the loan-loss provision ratio sits ~RMB 10.5 billion above the 2.5% regulatory floor; statically, this could absorb 2–3 years of the above shocks—but only if credit costs stop rising and balance-sheet growth slows. Yet in 1H26 the loan impairment provision balance grew only +0.29% in six months (loans +5.95%): the provision stock is being diluted. Additionally, the 12 consolidated village banks show an NPL ratio of 2.33% and provision coverage of 213.49%, weaker than the parent-level figures. Risks and falsification: Q3 retail NPLs rise above 2.35% with migration rates failing to recede; or the annual report shows the loan-loss provision ratio below 3.4% and coverage below 330%.
Key evidence:
The convergence of the governance discount depends on external events (appointment announcement → regulatory approval) with an uncontrollable timing: by the bank's own precedent (Chairman elected April 2025, approved January 2026, ~9 months), both positions are most likely filled in 2027—beyond the later part of this report's investment window. 1H26 operating data (revenue +7.81%) cannot yet prove "no transmission"—the reporting period ended June 30, before the president's July 22 resignation. The Q3 report covering July–September is the first testable window (watch retail lending, net deposit inflows, and whether approval timeliness is disrupted). Another governance friction signal: at the 2025-12-10 extraordinary general meeting, both the Articles of Association and the Board Rules resolutions drew 55.60% opposition from participating H-share shareholders. Risks and falsification: no disclosure of a new president by end-2026; a regulatory fine exceeding RMB 50 million per instance or an investigation opened against the bank.
| Metric | FY2023 | FY2024 | FY2025 | 2026Q1 | 2026H1 (latest period) |
|---|---|---|---|---|---|
| Operating revenue (RMB 100mn) | 279.56 | 282.62 | 286.48 | 78.30 | 158.92 (+7.81%) |
| Net profit attributable to parent (RMB 100mn) | 109.02 | 115.13 | 121.28 | 39.35 (+5.07%) | 81.68 (+6.09%) |
| Net profit attributable to parent excl. non-recurring items (RMB 100mn) | 106.49 | 111.44 | 120.97 | — | — |
| Net interest income (RMB 100mn) | 234.93 (-7.52%) | 224.95 (-4.25%) | 242.61 (+7.85%) | — | 135.29 (+15.20%) |
| Net fee and commission income (RMB 100mn) | 17.91 | 16.12 | 12.94 (-19.71%) | — | 8.21 (+5.24%) |
| Net interest margin (NIM) | 1.73% | 1.61% (unverified) | 1.60% (-1bp) | 1.69% | 1.66% (unverified, +6bp YoY) |
| NPL ratio | 1.19% | 1.18% | 1.08% | 1.07% | 1.05% (six consecutive declines) |
| Special-mention loan ratio | 1.14% | 1.46% | 1.42% | — | 1.40% |
| Provision coverage ratio | 366.70% | 363.44% | 367.26% | 365.72% | 357.47% |
| Loan-loss provision ratio | 4.37% | 4.28% | 3.96% | — | 3.74% |
| Core Tier 1 capital adequacy ratio | 13.53% (unverified) | 14.24%* (unverified) | 12.67% (unverified) | 12.25% | 12.33% (unverified) |
| ROE (weighted) | 9.58% (unverified) | 9.28% (unverified) | 9.18% (unverified) | — | 12.00% (annualized, unverified) |
| Cost-to-income ratio | 33.94% | 31.86% | 31.22% | 22.40% | 23.84% (-2.74pct) |
| Total assets (RMB 100mn) | 14,410.82 | 15,149.42 | 16,657.44 | — | 17,882.47 (+7.35% vs. beginning of year) |
| Total loans (RMB 100mn) | 6,767.11 | 7,142.73 | 7,972.87 (+11.62%) | — | 8,447.46 (+5.95% vs. beginning of year) |
| Total deposits (RMB 100mn) | 8,962.02 | 9,419.46 | 10,287.28 (+9.21%) | — | 10,890.55 (+5.86% vs. beginning of year) |
| Net assets per share (RMB) | 10.19 | 11.07 | 11.55 | — | 12.32 |
| Basic EPS (RMB) | 0.94 | 0.99 | 1.05 | — | 0.71 |
| DPS per share (RMB, pre-tax) | 0.2885 | 0.3046 | 0.32091 | — | — |
| Payout ratio | 30.05% | 30.05% | 30.05% | — | — |
Note: Banks have no meaningful gross margin / operating cash flow analysis / free cash flow / interest-bearing debt / net gearing metrics; in line with banking industry practice, this table substitutes net interest margin, asset quality, and capital adequacy ratios (see the "Business Model and Earnings Quality" chapter). "—" denotes not disclosed for the period or no verified figure obtained in this report. *The end-2024 Core Tier 1 capital adequacy ratio was measured under the new Administrative Measures for the Capital of Commercial Banks; the restructured RWA framework caused the jump and is not directly comparable with prior/subsequent years. As of 2026-10-27: total market cap RMB 82.3bn, PB(LF) 0.59x, PE(TTM) 6.54x (TTM attributable net profit RMB 12.598bn), dividend yield 4.43%.
Drivers of metric changes (line items with YoY ≥ ±20%, each with the company's explanation): ① Net fee income FY2025 -19.71%: the company attributed it mainly to "market conditions"; fees fell to 4.52% of revenue (a low among listed banks); ② Investment income + fair-value changes FY2024 +73.9% / FY2025 -22.2% / 2026H1 -30.0%: the company explained 2024 as "strengthened market analysis and seized trading opportunities," 2025 as "lower returns on trading financial assets such as fund investments," and 2026H1 as "moderately scaled back bond profit-taking"; ③ Net operating cash flow FY2025 -91.90% (RMB 372.3mn): no specific explanation (bank statements are distorted by deposit/lending and investment line items; this item carries no earnings-quality implication); ④ Restructured loans FY2024 +490.8%: no narrative attribution from the company (see the "Financial Engineering and Cross-Period Consistency" chapter); ⑤ Retail loan balance 2026H1 -7.06% vs. beginning of year: the company cited "recovery of some retail customers' income falling short of expectations and contraction in certain retail products"; ⑥ Other income (government grants) FY2025 -96.16%: due to adjustments in government grant policies; ⑦ Resale agreements (buy-back assets) FY2025 +63.33%: the company attributed it to adjustments in fund deployment for asset-liability and liquidity management; ⑧ Largest single-customer loan concentration 3.20%→7.00%: the company attributed it to "local SOE reforms, with individual group parent companies merging subsidiaries."
Revenue of RMB 15.892bn (+7.81%) is the highest growth rate in five years, with a "one up, one down" structure: net interest income of RMB 13.529bn (+15.20%) was the absolute main driver—volume (loans +5.95% and total assets +7.35% vs. beginning of year) and price (NIM 1.66%, unverified; the -22bp YoY decline in asset yields was more than offset by -30bp in funding costs) resonating; other non-interest income of RMB 1.542bn (-30.43%) dragged due to the company's proactive pullback in bond profit-taking—with this trade-off, revenue quality is actually improving (reduced reliance on mark-to-market bond gains). Net profit attributable to parent of RMB 8.168bn (+6.09%) trailed revenue growth due to impairment losses +12.03% YoY (RMB 1.997bn)—after boosting 2025 profit by provisioning less, 2026H1 swung to provisioning more; the engine of profit growth switched from provision releases to revenue-driven, which is the most important quality signal in this interim report. The cost-to-income ratio of 23.84% (-2.74pct) also contributed. Apparent asset quality continued to improve (NPL 1.05%, special-mention 1.40%), but leading indicators are diverging more widely (see C4). Period comparison: 2025H1 revenue grew only +0.46%, so this period's apparent high growth includes a low base (two-year CAGR ~4.1%); quarterly, Q1 +8.39% → Q2 ~+7.24%, a mild deceleration in momentum. On market expectations: no systematic consensus database is citable; external reference points are Citi (2026-10-15, via media) expecting Q3 earnings growth to accelerate to ~13% and maintaining "Buy" on the H-shares; tushare-aggregated A-share consensus FY2026 EPS of RMB 1.15 (+9.5%, 14 estimates), but consensus EPS was revised down -1.6% net over the past 90 days—this report's 5%–8% full-year profit growth assumption is below consensus; if Q3 delivers in line with Citi's view, that would create room for upward revisions to expectations.
Business model in brief: A typical county-level retail-focused rural commercial bank—on the liability side, county-level personal deposits are the "raw material" (county deposits account for 73.3%, pension disbursements to over 4.4mn people lock in low-cost funds, deposits are 66.4% of liabilities); on the asset side, it lends to corporate infrastructure/manufacturing/SMEs and individuals, plus RMB 737bn of financial investments (mainly bonds). Revenue structure: net interest income is 85.1% of revenue (2026H1), fees only 5.2%, and investment-related other non-interest ~9.5%—capital-intensive, weak fee income, no independent pricing power (average loan yield fell 3.92%→3.64%, offset by deposit cost rate falling 1.73%→1.45%).
Cash content and "recurring" test of earnings (banking framework): Industrial-style OCF/FCF tests are meaningless for banks (operating cash flow swung violently over three years from RMB 39.46bn → 4.60bn → 0.37bn, due to deposit/lending and investment line-item distortions, unexplained by the company). Three substitute tests: ① PPOP vs. net profit growth matching—FY2024/FY2025 PPOP +4.04%/+1.88% significantly lagged net profit +5.60%/+5.35%; in 2025 roughly half of profit growth came from lower provisioning; 2026H1 reversed to impairments +12.03% while net profit still grew +6.09%, with the growth engine switching to revenue—quality improving; ② The gap between non-recurring-excluded and reported profit is only 0.26% (FY2025 excl. non-recurring RMB 12.097bn vs. reported RMB 12.128bn); one-off items are negligible—no "one-off gain window dressing"; ③ Bank self-reported figures have no room for Non-GAAP adjustments; no aggressive items like SBC add-backs exist.
Return on capital: FY2025 weighted ROE 9.18% (2026H1 annualized 12.00%), versus this report's cost-of-equity assumption of 9.5%–10%—barely covering the cost of capital, far from a wide moat. ROE is on a long-term downtrend (weighted: FY2023–FY2025 at 9.58%→9.28%→9.18%); management stated in the interim report that "attributable net profit growth of 5.46% is below net asset growth of 6.51%, and we strive to keep ROE broadly stable."
Capital expenditure and internal replenishment (CapEx substitute test): Banks have no CapEx/depreciation concept; the substitute is capital endogeneity—RWA grew +16.53% in 2025 and another +10.46% in 2026H1 (annualized ~21%), while profit retention adds only ~6.5% per year; the Core Tier 1 capital adequacy ratio fell continuously from 12.67% (end-2025, -1.57pct for the year, unverified) to 12.33% (2026H1, unverified) (end-2024's 14.24% is not comparable due to the new capital rules). The company's 2026–2028 capital plan is "internal sources first, external sources supplementary"; external instruments (Tier 2 bonds/perpetual bonds) do not replenish Core Tier 1, so if double-digit balance-sheet expansion continues, 2027–2028 will force a choice among "slower growth / lower dividends / dilutive refinancing"—the most substantive medium-term constraint in the earnings-quality dimension.
Red flags and concentration: ① Revenue reliance on bond investment returns (investment income + fair-value changes fluctuated at 7.9%→13.6%→10.4%→9.5% of revenue; a rate reversal would stall growth); ② Balance-sheet expansion outpacing internally generated capital (above); ③ Largest single-customer concentration 3.20%→7.00% (caused by SOE mergers; local state-capital exposure concentration needs monitoring); ④ No large-customer dependence on deposits (personal deposits dominate)—overall customer concentration does not constitute a red flag.
Consistency of words and deeds: The company has no practice of quantitative guidance; annual operating plans are qualitative ("five major articles," "one body, four drivers," "three new growth engines"); the 2025 annual report self-assessed as having "fairly well achieved annual operating targets"—qualitative commitments cannot be falsified and can only be judged by outcomes: 2025 revenue +1.37% / attributable profit +5.35%, 2026H1 revenue +7.81%—directionally delivered. Management's annual NIM judgment (2025 annual report: "the rate center will keep declining in 2026 and NIM pressure will be significant") proved conservative versus reality (H1 +6bp against the trend). Overall verdict: pragmatic and somewhat conservative, no record of exaggeration, but weak verifiability. Shareholder friendliness: Payout ratio at exactly 30.05% for three years, DPS up three years running, interim dividends institutionalized since 2024, zero share issuance/dilution over three years (Tier 1 capital via RMB 6bn perpetual bonds), no buybacks—shareholder-friendly (dividend dimension); but the "neat" 30.05% also implies the ratio is a budget-constraint ceiling rather than a parameter that can be raised. Risk signals: ① The President and Chief Compliance Officer posts have both been vacant for over 3 months, with the Chairman acting in their capacity; investors have publicly questioned the "overdue acting arrangements"; ② The former Chairman (17 years in office) was placed under investigation in September 2026; retrospective business risk from his tenure is undetermined; ③ Fines and confiscations totaling RMB 13.53mn in 2025, including a single RMB 8.7mn penalty in December that led to lifetime industry bans for two executives; ④ At the December 2025 EGM, two charter-related resolutions were opposed by 55.60% of participating H-share holders—governance friction became overt. Overall: dividend-friendly, with a relatively weak governance and compliance record—the latter being part of the valuation discount (corresponding to C5).
| Segment | Revenue share | YoY | Segment logic and asset quality |
|---|---|---|---|
| Retail banking (inclusive finance) | 42.43% | +2.58% | County-level personal deposits/lending + SMEs; the deposit base (county deposits 73.3%, personal deposit cost rate 1.51%); asset side under pressure: retail NPL 2.23%, consumer loans 3.31%, retail balance -7.06% in 2026H1 vs. beginning of year |
| Corporate banking | 32.67% | +8.29% | Corporate + institutional; corporate loans +21.46% in 2025 as the main expansion driver; corporate NPL 0.55% with a "double decline"—currently the "optimal segment" for growth and asset quality |
| Financial markets | 24.54% | -8.73% | Treasury operations + bond investing; the main source of earnings volatility (2026H1 other non-interest -30.43%); financial investments of RMB 737bn, +14.51% in six months—scale expansion and interest-rate risk accumulating in tandem |
Banks have no gross margin concept; substitute with "growth × asset quality": judgment on the profit engine—the corporate segment provided the main growth elasticity in 2025–2026 (volume growth + NPL double decline); the retail segment provides the funding-cost advantage (the root of NIM stabilization); the financial markets segment is a volatility item, not a trend item, in revenue. The cross-segment "gross margin" structural difference lies in NIM sources: retail deposit stickiness (cost rates 1.31%–1.51%) and corporate asset pricing (yields declining but volume +21%) together support a NIM 25bp above the industry average.
Accounting red flags (all with original-text evidence): ① Under-provisioning to prop up profit (severity: medium)—FY2025 credit impairments of RMB 5.444bn, -8.61% YoY; the company stated loan impairment reductions of RMB 440mn were due to "recoveries from disposal of large non-performing assets," and financial-investment reductions of RMB 246mn were due to "provisioning already made on a forward-looking basis"; meanwhile PPOP was only +1.88% vs. net profit +5.35%. 2026H1 swung to heavier provisioning (+12.03%), so this red flag is easing at the margin, but the historical pattern warrants vigilance against repetition. ② Surge in restructured loans without explanation (severity: medium)—restructured loans rose from 0.09% of loans in FY2023 to 0.51% in FY2024 (+490.8%) to 0.51% in 2026H1 (balance up another +23.8%), with no attribution anywhere in the annual report; possible deferral of risk recognition within grace periods. ③ Overdue loans diverging from NPLs (severity: medium)—2026H1 overdue loans of RMB 10.578bn, +RMB 1.108bn vs. end of prior year (overdue ratio 1.25%, +0.06pct), with the 3-month-to-1-year overdue balance +30.6%, while the NPL ratio fell to 1.05%—potential deterioration pressure not yet fully recognized on balance sheet. ④ Jump in single-customer concentration (severity: low)—3.20%→7.00%, attributed to SOE mergers; trend requires monitoring. Cross-period consistency: ① Loan-loss provision ratio falling continuously at 4.37→4.28→3.96→3.74, while management's statement of "provision levels stable with a slight rise" refers only to the coverage-ratio measure—selective framing inconsistent with disclosures; ② Special-mention ratio jumped 0.32pct in 2024 (1.14%→1.46%) without attribution; in 2025 the company only noted "down 0.04pct vs. end of prior year," sidestepping the jump—unexplained by the company; ③ PPOP diverging from net profit growth (2025) → reversal in 2026H1—consistent with the company's explanation (provisioning shifted from lighter to heavier); ④ Restructured loans remaining elevated—unexplained by the company; ⑤ Violent swings in operating cash flow—unexplained by the company (industry norm). Overall: two medium-severity red flags and three "unexplained" cross-period anomalies, concentrated in provisioning and retail asset quality—this warrants a necessary discount to the "six consecutive NPL declines" narrative, and is why this report treats retail NPLs as a key constraint (C4) rather than simply trusting the headline metrics.
Current market data and percentiles: Share price CNY 7.25 (close of 2026-10-27), total market cap CNY 82.3 billion; PB(LF) 0.59x (BPS CNY 12.32), at the 77th percentile over the past 1 year and the 88th percentile over the past 5 years (the banking sector rally has repaired most of the discount; not cheap on a vertical basis); PE(TTM) 6.54x (89th percentile over the past 5 years); dividend yield 4.43%. Liquidity risk is not applicable (A-share free float market cap of approximately CNY 64 billion; average daily turnover far exceeds the 0.1% market cap threshold).
What expectations the market has already priced in: Back-solving from PB-ROE (r=9.75%, g=2.5%) shows the current price of 0.59x PB implies a sustainable ROE of about 6.8%; applying a higher risk premium for retail credit risk (r=11%) implies roughly 7.5%. The current price requires the market to believe that "CQRC Bank's long-term ROE is only 6.8%–7.5%," whereas reality is around 9.2% on a full-year basis with a stabilizing trend—a gap of about 2 percentage points, with the market primarily discounting for the retail NPL cycle, regional LGFV exposure, and governance uncertainty. For comparison: peers' 0.66–0.67x PB implies roughly 7.3%; under a sector-wide common discount, the stock's additional discount versus peers is about 1 percentage point of ROE—the verifiable mispricing component (corresponding to C2). Three-layer value (EPV): Asset value layer—tangible book value per share of approximately CNY 12.2 (liquidation basis has limited meaning for banks, used as a floor reference; the 1-year PB low of 0.52x corresponds to about CNY 6.4, and the 5-year extreme of 0.37x serves as a tail reference); EPV zero-growth layer—a bank with zero growth can distribute all earnings, FCFE ≈ net profit; taking a sustainable EPS of CNY 1.06 (between FY2025 reported 1.05 and TTM 1.11, conservatively) divided by cost of equity of 9.75%, EPV ≈ CNY 10.87/share; growth option layer—the current price of CNY 7.25 is at a ~33% discount to zero-growth EPV, with the growth option value negative (about -50%): the market is not only paying nothing for growth but also applying a deep discount to earnings sustainability itself. This structure is the norm in the A-share banking sector (peers carry the same discount); the stock-specific opportunity lies in relative convergence of the discount rather than absolute re-rating. Limitations of absolute valuation inputs: no loan-by-loan credit adjustment of the loan book was performed; EPV is based on reported earnings and does not strip out possible under-provisioning—if C4's concerns materialize, EPV itself faces downside revision risk. Three scenarios and odds (valuation reference date 2026-10-27, anchor CNY 7.25):
| Scenario | Probability | Fair Value Range (CNY) | vs. Current Price | Key Drivers |
|---|---|---|---|---|
| Bear | 25% | 6.0–6.5 (0.48–0.52x × 2026E BPS 12.4) | -17% to -10% | Retail NPLs rise above 2.35% with migration rates not reverting + credit cost normalization + governance incident escalation; market's pessimistic expectations validated |
| Base | 50% | 7.7–8.1 (0.62–0.65x) | +6% to +12% | NIM holds above 1.64%, retail NPLs stabilize, earnings grow +5%–8% sustained, PB converges toward peer median (anchor: comparable peers' median of 0.67x as of 2026-10-27, with a 3%–7% discount for unresolved risks) |
| Bull | 25% | 8.7–8.9 (0.70–0.72x) | +20% to +23% | NIM rises above 1.7% + retail NPL inflection confirmed + ROE solidly above 12% + new president appointment finalized + dividend/index fund allocation increases; valuation in line with or slightly above peer median |
The distribution is right-skewed but modest in magnitude: probability-weighted expected value of CNY 7.71 (+6.4%), overlapping with the base-case floor—odds are symmetric with a slight upward tilt; the payoff comes from "discount convergence + dividends," not from an "earnings surge." In-house forecasts vs. external benchmarks: this report's FY2026 revenue of CNY 30.2–30.8 billion (+5.4% to +7.5%) and net profit attributable to parent of CNY 12.8–13.15 billion (+5.6% to +8.4%, midpoint +7%), below sell-side consensus (EPS CNY 1.15, +9.5%) and close to management's conservative tone; sell-side target prices: A-share consensus median of CNY 8.5 (19 institutions, +17% vs. current price, aggregated via tushare as of 2026-10-27), Citi's H-share target of HKD 8.37 (2026-10-15, as reported by media)—this report's base-case range is about 8% more conservative than consensus, mainly due to greater caution on the 2027 growth rate (+4%–6%) after the fade of provision releases. DDM cross-check: DPS CNY 0.321, r=9.75%, g=3.5% gives approximately CNY 5.4 (pure dividend basis, excluding retained earnings accretion; a systematically low bound); full-payout equivalent basis (EPS/r) of CNY 15.5–19.9 (upper bound)—the current price of CNY 7.25 falls between the two bases, toward the lower end, mutually corroborating the "implied ROE discount" conclusion. Conclusion: reasonably undervalued; target price CNY 7.7–8.1, safety margin of approximately +6%. Quality (trillion-yuan sector leader, provision coverage in the top tier among peers, one of the first to stabilize NIM) and price (11%–12% cross-sectional discount) should be assessed separately: above-average quality, modestly undervalued price; upside is constrained by its own percentile levels and sector crowding—position sizing should not treat it as "deeply undervalued."
Industry size and growth: Total assets (RMB and foreign currency) of China's banking institutions reached RMB 498 trillion (end of 2026Q2, NFRA basis, +6.6% YoY), of which large commercial banks accounted for RMB 221.6 trillion (+8.5%); the rural commercial bank segment's total assets were RMB 62.28 trillion (end of 2026H1, 12.73% of the banking sector, only +2.27% vs. end-2025)—a clear "K-shaped" pattern of mid-single-digit growth in overall industry volume and near-stagnant balance sheet expansion in the rural commercial bank segment. Growth outlook: no authoritative public consensus forecasts exist for 2027–2029; "slowing credit growth" is the consensus direction. Structural demand inflection: none exists—the banking industry has no exogenous demand-repricing variable of the "downstream platform/technology shift" type; the most significant marginal change currently is the cyclical bottoming of net interest margins (commercial banks' NIM touched a record low of 1.40% in 2026Q1, then rebounded 1bp to 1.41% in Q2—the first quarter-over-quarter increase since 2022; regulatory data released in 2026-08)—a cyclical inflection rather than a structural one. Value chain and value distribution: A bank's "upstream" is liability-side funding (deposits are the core raw material), and its "downstream" comprises agriculture/rural residents, small and micro enterprises, county-level residents, and local infrastructure entities. CQRC Bank operates across the full intermediation chain; value (NIM) is retained in the scissors gap between funding cost and asset pricing: its nominal pricing power over downstream small/micro clients and farmers is stronger than the big banks (NIM of 1.66% is 25bp above the commercial bank average of 1.41% and above the rural commercial bank segment average of 1.59%), while on the liability side it locks in low-cost funding through county-level branch networks and payroll/ecosystem relationships (personal deposit cost rate of 1.31%). Margin pressure comes from both ends—asset-side LPR declines (1-year at 3.0%, unchanged for 17 consecutive months) and liability-side big-bank downward expansion bidding up deposits. Margin (spread) is retained in the link of "county-level liability stickiness + inclusive asset pricing"—precisely where this bank's moat lies. Supply-demand and competitive landscape: Demand side—Chongqing loan balance of RMB 6.68 trillion (end of June 2026, +4.1% YTD), with demand driven primarily by Chengdu-Chongqing economic circle and New Western Land-Sea Corridor infrastructure, as well as regulatory-directed inclusive small/micro lending; supply side—big banks' downward expansion is the largest supply shock (big banks' total asset growth of +8.5% outpaces the industry; LPR-below-benchmark loans approach 50%). The Chongqing market shows a "local duopoly + multi-player national bank competition" pattern: CQRC Bank holds roughly 17.0% deposit share and roughly 12.6% loan share (group consolidated/citywide basis, upper bound, June 2026, own estimate), Bank of Chongqing roughly 9.8%/8.7% respectively; the two local institutions combined hold approximately 26.8% deposit share, with the remaining 60%+ shared among big banks' and joint-stock banks' branches, Three Gorges Bank, and village banks—a moderately low-concentration, price-competitive landscape. Barriers to entry: licenses (no new banking licenses issued), physical branches (about 80% of the bank's branches are in county areas, covering all 38 districts/counties of Chongqing), and regulatory "agriculture and small business support" mandate constraints. Substitution threats: direct financing diverting large corporates, internet lending platforms diverting retail small/micro business, and wealth management products/money market funds diverting savings. Cycles and regulation: Cyclical position—after four years of NIM decline, the industry has entered "oscillating bottoming" (2026Q2 saw the first quarter-over-quarter rebound; leading indicators: repricing benefits from multiple rounds of listed deposit rate cuts, LPR quotations, and the maturity schedule of high-rate time deposits), with K-shaped divergence in profitability (commercial banks' 2026H1 net profit -0.6%, rural commercial bank segment -12.56%, while all 12 listed rural commercial banks posted positive attributable profit growth). Regulation—① LGFV debt resolution: 2026 is a critical implementation year (RMB 2 trillion special refinancing bonds for swaps); Chongqing's swap funds arrived quickly and early redemption of LGFV bonds is reducing exposure (Dagong Global, 2026-09-29)—a double-edged sword for this bank of "asset quality relief vs. high-yield assets being swapped away"; direct county-level credit exposure is limited (Lianhe Credit); ② deposit rate marketization: multiple rounds of listed rate cuts (1-year time deposits below 1%) plus the central bank phasing out benchmark rates are the main driver of this round's NIM stabilization, with benefits continuing over coming quarters; ③ new capital rules (effective 2024) differentiated regulation lowers compliance costs for small and medium banks; ④ rural financial institution reform and risk resolution: over 400 rural financial institution legal entities were reduced in January–September 2026, with village banks being absorbed and merged at an accelerating pace—this bank completed single-legal-entity consolidation years ago and benefits as a consolidator rather than a consolidatee. Peer benchmarking (see charts in the valuation chapter; company data on 2026 interim report basis): Changshu Bank (micro-lending benchmark, NIM 2.48%/ROE 13.34%/NPL 0.75%/provision coverage 431.9%, PB 0.67) leads comprehensively in earnings quality but is only 1/4 this bank's size; Shanghai Rural Commercial Bank (NIM 1.36%/ROE 10.76%/attributable profit +0.87%, PB 0.66) has a better location but weaker NIM and growth than this bank; Bank of Chongqing (NIM 1.46%/NPL 1.11%/CET1 of only 8.56%, PB 0.67) is the direct same-city competitor, weaker in both capital and asset quality; Qingdao Rural Commercial Bank (revenue -7.57%, NPL 1.7%+) is a weak-location stress sample. This bank trades at the lowest PB of the four at 0.59x, while ranking in the top two on ROE, NIM, provisions, and CET1—the cross-sectional mismatch is evident. Industry positioning: First among the top tier of listed rural commercial banks nationwide—total assets of RMB 1,788.2 billion rank first among the 12 listed rural commercial banks (with Shanghai Rural Commercial Bank, the only two above RMB 1.6 trillion), one of 5 trillion-yuan rural commercial banks nationwide, accounting for approximately 2.87% of the national rural commercial bank segment's total assets; absolute leader in Chongqing (deposits and loans ranked first for many years; agriculture-related loans of RMB 270 billion and inclusive small/micro loans of RMB 145.5 billion both rank first in Chongqing). Basis note: "first among listed rural commercial banks" is per the 2026 interim report compilation by Xinhua Finance/Bread Finance; the national rural commercial bank ranking is on the regulatory institution category basis (Chongqing Rural Commercial Bank has long ranked first)—the two do not conflict. Share trends are improving (2025 annual report disclosed year-over-year increase in deposit/loan incremental market share). Moat: county-level physical capillary network (not replicable by big banks in the short term) + liability stickiness from pension disbursement business + completed A+H listing governance framework. No substantive conflict between the company's self-claimed industry position and third-party assessments.
① NIM decomposition: NIM 1.73% (unverified) → 1.61% (unverified) → 1.60% (FY2023–FY2025 declining year by year) → 1.69% (2026Q1) → 1.66% (2026H1, +6bp YoY, unverified). The improvement is entirely liability-driven: asset yields -22bp YoY (loan yield 3.92%→3.64%), liability costs -30bp (deposit cost rate 1.73%→1.45%, personal deposit cost rate 1.31%)—deposit repricing benefits still have room to be released (maturity of high-rate time deposits continues into 2027), but asset-side declines have not ended; NIM "stabilization" is a dynamic balance of a two-sided race, not a one-sided trend reversal. ② Asset quality panorama (five-category classification + migration + restructuring): NPL ratio 1.05% (six consecutive declines), special-mention 1.40%, overdue 1.25% (+0.06pct)—superficially the best in history; but all four migration rates rose (normal 1.31→1.63, special-mention 19.73→36.68, substandard 73.54→87.21, doubtful 36.21→42.35), restructured loans 0.51% (+23.8% in half a year), retail NPLs 2.23% (consumer category 3.31%), consolidated village bank NPLs 2.33%/provision coverage 213.49%—forward-looking indicators weaker than headline ones (corresponding to C4 and the accounting-techniques chapter). NPL recognition deviation ratio (90+ days overdue/NPL) at 72.4%, below 100% indicating overall prudent recognition. ③ Capital trilemma: CET1 of 12.33% (unverified, among the highest of peers), but down approximately 1.9pct since 2025 (14.24%→12.67%→12.33%, all unverified; the first-period decline includes the impact of the new capital measures basis switch); the gap between RWA growth (2025 +16.5%) and retained-earnings replenishment (~6.5%/year) persists. Scenario analysis: RWA growth of 10% per year leaves CET1 at roughly 11.2% in three years (manageable); sustaining 15% would push it below 10% (triggering a refinancing decision). Cutting the payout ratio to 25% only raises retention to 6.9%/year and cannot replace refinancing—a choice among "slower growth / lower dividends / dilution" is expected to become explicit in 2027–2028. ④ Dividends and A/H structure: Payout ratio constant at 30.05% for three years, with interim dividends institutionalized (2026 interim dividend to be approved by the board in December, estimated at approximately CNY 0.21–0.22 per share); H shares represent 22.08% of total share capital (nominally held by HKSCC); H shares trade at roughly a 20% discount to A shares (18.9% on the 2026-02 basis; H shares around HKD 6.3–6.5 in 2026-10), with an H-share dividend yield of approximately 5.7% (aggregated basis, to be verified) representing an alternative for A-share dividend funds within the same company—the incremental capital required for A shares to converge to 0.65x (insurers/southbound/passive funds) is the funding-side prerequisite for valuation realization.
Overall verdict: cautiously bullish, confidence 0.55, time horizon 6–12 months. Quality and price assessed separately: above-average quality (trillion-yuan rural commercial bank leader, among the first to stabilize NIM, thickest provision coverage tier, highest CET1 among peers), modestly undervalued price (11%–12% cross-sectional discount, implied ROE gap of about 2pct, current price at a ~33% discount to zero-growth EPV), but vertical percentiles are already high, the sector is crowded, and governance and retail NPL issues remain unresolved—upside relies on "discount convergence + 4.4% dividend yield," downside protection against "credit cost normalization + governance escalation." Strategically, a dividend-core position built in batches is appropriate, with position discipline anchored to the bear-case floor; the 10-29 Q3 report is the first verification checkpoint—if results meet expectations (9M26 NIM ≥1.64%, retail NPLs ≤2.23%, quarterly profit ≥+11%), hold into the base-case range; if below expectations, treat per the falsification line.
Risk and catalyst summary (written record): Upside catalysts—Q3 results beat (Citi basis quarterly +13%), December interim dividend implementation (≥CNY 0.23 per share would be a beat), new president appointment approval, debt-resolution relief for regional asset quality, insurer/southbound allocation increases. Downside risks—continued rise in retail NPLs and migration rates, accelerating drawdown of loan-loss provision ratio, bond market rate reversal hitting investment income (mark-to-market exposure of approximately RMB 466.3 billion; scenario of +50bp in yields implies net assets of approximately -3.1%), governance incident escalation (a single large fine or investigation), sector dividend-style retreat, dilutive refinancing proposals. All conditions have been incorporated into the monitoring checklist; re-evaluation upon trigger.
Data and basis notes: Financial data as of 2026H1 (disclosed 2026-08-31); the 2026 Q3 report is scheduled for board review and disclosure on 2026-10-29, at which point the latest period results will be updated. Price basis is the A-share closing price of CNY 7.25 on 2026-10-27; peer multiples are all calculated on a same-basis using 2026-10-27 closing prices / each bank's 2026H1 BPS. This report is compiled from publicly disclosed documents and public news/research reports; cited materials are as noted in the text. The few indicators marked (unverified)—NIM for FY2023/2024/2026H1, CET1 ratios for each period, weighted ROE for each year, and 2026H1 annualized ROE—are taken from the company's periodic report disclosures but were not re-verified through this system's verification pipeline; please refer to the company's original periodic reports when citing.